The IRF5 polymorphisms associated with an increased risk of developing SLE and other autoimmune diseases are in the noncoding region of the IRF5 gene and show some association with increased IRF5 expression and/or functional change (3, 20). This evidence concerns the gene IRF5 and systemic lupus erythematosus.